Literature DB >> 23021150

Peripheral nerve injury produces a sustained shift in the balance between glutamate release and uptake in the dorsal horn of the spinal cord.

Perrine Inquimbert1, Karsten Bartels, Olusegun B Babaniyi, Lee B Barrett, Irmgard Tegeder, Joachim Scholz.   

Abstract

Peripheral nerve injury provokes heightened excitability of primary sensory afferents including nociceptors, and elicits ectopic activity in lesioned and neighboring intact nerve fibers. The major transmitter released by sensory afferents in the superficial dorsal horn of the spinal cord is glutamate. Glutamate is critically involved in nociceptive signaling and the development of neuropathic pain. We recorded miniature excitatory postsynaptic currents (mEPSCs) from neurons in lamina II of the rat dorsal horn to assess spontaneous synaptic activity after spared nerve injury (SNI), a model of chronic neuropathic pain. Following SNI, the frequency of mEPSCs doubled, indicating heightened glutamate release from primary afferents or spinal interneurons. Consistent with this finding, glutamate concentrations in the cerebrospinal fluid were elevated at 1 and 4 weeks after SNI. Transmitter uptake was insufficient to prevent the rise in extracellular glutamate as the expression of glutamate transporters remained unchanged or decreased. 2-Methyl-6-(phenylethynyl)pyridine hydrochloride, an antagonist of metabotropic glutamate receptor 5 (mGluR5), reduced the frequency of mEPSCs to its preinjury level, suggesting a positive feedback mechanism that involves facilitation of transmitter release by mGluR5 activation in the presence of high extracellular glutamate. Treatment with the β-lactam antibiotic ceftriaxone increased the expression of glutamate transporter 1 (Glt1) in the dorsal horn after SNI, raised transmitter uptake, and lowered extracellular glutamate. Improving glutamate clearance prevented the facilitation of transmitter release by mGluR5 and attenuated neuropathic pain-like behavior. Balancing glutamate release and uptake after nerve injury should be an important target in the management of chronic neuropathic pain.
Copyright © 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021150      PMCID: PMC3540793          DOI: 10.1016/j.pain.2012.08.011

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  28 in total

1.  Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes.

Authors:  Geraldine T Petr; Yan Sun; Natalie M Frederick; Yun Zhou; Sameer C Dhamne; Mustafa Q Hameed; Clive Miranda; Edward A Bedoya; Kathryn D Fischer; Wencke Armsen; Jianlin Wang; Niels C Danbolt; Alexander Rotenberg; Chiye J Aoki; Paul A Rosenberg
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

2.  Peripheral metabotropic glutamate receptor subtype 5 contributes to inflammation-induced hypersensitivity of the rat temporomandibular joint.

Authors:  Bo Li; Li Lu; Xuexin Tan; Ming Zhong; Yan Guo; Xin Yi
Journal:  J Mol Neurosci       Date:  2013-06-27       Impact factor: 3.444

Review 3.  Toward a Mechanism-Based Approach to Pain Diagnosis.

Authors:  Daniel Vardeh; Richard J Mannion; Clifford J Woolf
Journal:  J Pain       Date:  2016-09       Impact factor: 5.820

4.  Impaired sensitivity to pain stimuli in plasma membrane calcium ATPase 2 (PMCA2) heterozygous mice: a possible modality- and sex-specific role for PMCA2 in nociception.

Authors:  Veronika Khariv; Li Ni; Ayomi Ratnayake; Sujitha Sampath; Brianna M Lutz; Xuan-Xiang Tao; Robert F Heary; Stella Elkabes
Journal:  FASEB J       Date:  2016-10-04       Impact factor: 5.191

5.  Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception.

Authors:  Eyup Akgün; Muhammad I Javed; Mary M Lunzer; Branden A Smeester; Al J Beitz; Philip S Portoghese
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

6.  Inhibition of the kinase WNK1/HSN2 ameliorates neuropathic pain by restoring GABA inhibition.

Authors:  Kristopher T Kahle; Jean-François Schmouth; Valérie Lavastre; Alban Latremoliere; Jinwei Zhang; Nick Andrews; Takao Omura; Janet Laganière; Daniel Rochefort; Pascale Hince; Geneviève Castonguay; Rébecca Gaudet; Josiane C S Mapplebeck; Susana G Sotocinal; JingJing Duan; Catherine Ward; Arjun R Khanna; Jeffrey S Mogil; Patrick A Dion; Clifford J Woolf; Perrine Inquimbert; Guy A Rouleau
Journal:  Sci Signal       Date:  2016-03-29       Impact factor: 8.192

7.  Presynaptic mGluR5 receptor controls glutamatergic input through protein kinase C-NMDA receptors in paclitaxel-induced neuropathic pain.

Authors:  Jing-Dun Xie; Shao-Rui Chen; Hui-Lin Pan
Journal:  J Biol Chem       Date:  2017-10-26       Impact factor: 5.157

8.  Chronic at-level thermal hyperalgesia following rat cervical contusion spinal cord injury is accompanied by neuronal and astrocyte activation and loss of the astrocyte glutamate transporter, GLT1, in superficial dorsal horn.

Authors:  Rajarshi Putatunda; Tamara J Hala; Jeannie Chin; Angelo C Lepore
Journal:  Brain Res       Date:  2014-05-14       Impact factor: 3.252

Review 9.  Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior.

Authors:  Kathryn D Fischer; Lori A Knackstedt; Paul A Rosenberg
Journal:  Neurochem Int       Date:  2020-11-05       Impact factor: 3.921

10.  Evidence for glutamate as a neuroglial transmitter within sensory ganglia.

Authors:  Ling-Hsuan Kung; Kerui Gong; Mary Adedoyin; Johnson Ng; Aditi Bhargava; Peter T Ohara; Luc Jasmin
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.